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Abstract
Neurogenin3+ (Ngn3+) progenitor cells in the developing pancreas give rise to five endocrine cell types secreting insulin,
glucagon, somatostatin, pancreatic polypeptide and ghrelin. Gastrin is a hormone produced primarily by G-cells in the
stomach, where it functions to stimulate acid secretion by gastric parietal cells. Gastrin is expressed in the embryonic
pancreas and is common in islet cell tumors, but the lineage and regulators of pancreatic gastrin+ cells are not known. We
report that gastrin is abundantly expressed in the embryonic pancreas and disappears soon after birth. Some gastrin+ cells
in the developing pancreas co-express glucagon, ghrelin or pancreatic polypeptide, but many gastrin+ cells do not express
any other islet hormone. Pancreatic gastrin+ cells express the transcription factors Nkx6.1, Nkx2.2 and low levels of Pdx1, and
derive from Ngn3+ endocrine progenitor cells as shown by genetic lineage tracing. Using mice deficient for key transcription
factors we show that gastrin expression depends on Ngn3, Nkx2.2, NeuroD1 and Arx, but not Pax4 or Pax6. Finally, gastrin
expression is induced upon differentiation of human embryonic stem cells to pancreatic endocrine cells expressing insulin.
Thus, gastrin+ cells are a distinct endocrine cell type in the pancreas and an alternative fate of Ngn3+ cells.
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Introduction
The islets of Langerhans are composed of 4 main endocrine cell
types: beta cells secreting insulin, alpha cells secreting glucagon,
delta cells secreting somatostatin, and PP cells secreting pancreatic
polypeptide. These cells all derive from endocrine progenitor cells
in the embryonic pancreas, marked by expression of the
transcription factor neurogenin3 (Ngn3) [1,2]. Ngn3+ cells also
give rise to epsilon cells expressing ghrelin, which disappear
around 10 days after birth in mice [3]. A hierarchy of transcription
factors orchestrates the formation of endocrine cells from Ngn3+
progenitors, and mutations in such factors perturb or skew the
specification of endocrine cell types. The mechanisms that control
the formation of endocrine cells are under intense investigation, in
part in the context of efforts to generate transplantable beta cells
from embryonic stem cells for the treatment of diabetes.
In parallel to its function in the developing pancreas, Ngn3
controls the formation of enteroendocrine cells in the gastrointes-
tinal tract, which secrete, among others, the hormones secretin,
gastrin, GIP, GLP, somatostatin and CCK [4,5]. While Ngn3
appears to be a master regulator of the generic gut/pancreas
endocrine program, it is not clear why different hormones are
produced by the pancreatic and the intestinal derivatives of Ngn3+
cells. Here we focus on gastrin, a hormone secreted from
endocrine G cells located mainly in the gastric antrum [6–8].
The gastrin peptide induces acid secretion and gastric motility,
and stimulates mucosal proliferation [9–11]. Gastric G cells derive
from Ngn3+ enteroendocrine progenitor cells [4], and their
formation requires Nkx2.2 and Arx in addition to Ngn3 [12,13].
Interestingly, although Ngn3 positive cells are present in the
mouse embryonic gut by embryonic day 12.5 [14], the expression
of gastrin in the stomach begins only postnataly, so that in fetal life,
gastrin is mostly found in the pancreas, in both rodents and
humans [15–17]. Pancreatic gastrin expression disappears after
birth, but can reappear pathologically in the form of gastrin-
secreting neuroendocrine tumors (gastrinomas), most of which are
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malignant [18,19]. Very little is known about the origins and the
molecular determinants of pancreatic gastrinomas and fetal
pancreatic gastrin expression. Here we use a combination of
expression analysis, genetic lineage tracing and gene knockouts to
study gastrin expression in the embryonic pancreas. We demon-
strate that G cells represent a distinct, 6th endocrine cell type in
the embryonic pancreas, and an alternative fate of Ngn3
endocrine progenitor cells.
Results
Expression of gastrin in the embryonic pancreas
To study gastrin expression in the pancreas at high resolution,
we used immunostaining and confocal microscopy. In adult mice,
gastrin+ cells were observed as expected in the stomach but not in
the pancreas (not shown). Consistent with previous reports on
gastrin mRNA expression [17], we observed a particularly
dramatic abundance of gastrin+ cells in explants of e12.5
pancreata cultured for 3 days (Fig. 1A). This observation was
repeated in e14.5 embryonic pancreas where numerous gastrin+
cells were seen (Fig. 1B). By immunofluorescence, in both samples,
gastrin+ cells appeared to be nearly as abundant as insulin+ cells.
FACS analysis of dissociated embryonic pancreata confirmed this
observation, demonstrating that 0.6% of the cells expressed gastrin
while 0.7% expressed insulin; Fig. 1C and Fig. S1). Gastrin
expression declined with embryonic age, essentially disappearing
by post-natal day 7 (Fig. 1D).
We then characterized the expression of gastrin in the e15.5
mouse embryonic pancreas, and determined the specific cell type
expressing gastrin. Co-staining for gastrin and each islet hormone
revealed that gastrin+ cells did not co-express insulin or
somatostatin (Fig. 2A, B). In contrast, gastrin+ cells often co-
expressed glucagon (53%), ghrelin (22%) or pancreatic polypeptide
(17%) (Fig. 2C–E and 2K). Glucagon and ghrelin are co-expressed
in endocrine cells during pancreas development. In order to
determine whether there are gastrin+ cells that do not co-express
these two hormones we co-stained for gastrin, glucagon and
ghrelin and found gastrin+ cells that did not express ghrelin or
glucagon (Fig. 2F). To further test if there were gastrin+ cells that
did not express any of the known pancreatic hormones, we co-
stained for gastrin and a cocktail of antibodies directed against
insulin, glucagon, ghrelin, pancreatic polypeptide and somatostat-
in. As shown in Fig. 2G–H and Fig. S2, there were many gastrin+
cells that did not express any other pancreatic hormone (40%,
Fig. 2K). Similar results were obtained when a different gastrin
antibody was used to stain the pancreas of the gerbil, Psammomys
obesus, demonstrating that our findings are not limited to mice. At
e22 (equivalent to mouse e15.5), gastrin+ cells were readily
identified which did not stain for either insulin or glucagon
(Fig. 2I). Additionally, we stained e22 Psammomys obesus pancreata
with the same cocktail used on mouse pancreata and observed
gastrin+ cells that do not express any other pancreatic hormone
(Fig. 2J).
Most existing gastrin antibodies, including those used for the
above experiments, cross-react with Cholecystokinin (CCK), a
similar hormone that shares with gastrin the amino acid sequence
that binds the CCKB receptor and has been reported in the
embryonic pancreas. However, CCK expression was only
reported in mice from gestational day 16 and beyond, and nearly
all CCK+ cells co-express glucagon [6], suggesting that our
immunostaining identified gastrin+ and not CCK+ cells. To further
confirm this, we used an antibody that does not cross react with
CCK (Abnova) and, using this specific antibody, demonstrated
gastrin-expressing cells at e15.5 (Fig. S3). As an additional proof,
our mRNA analysis (see below) is specific for gastrin, further
validating the identification of gastrin. Taken together, these
results show that gastrin+ cells represent a distinct hormone cell
type generated in the embryonic pancreas.
Gastrin is expressed in cells positive for Nkx2.2, Nkx6.1
and low Pdx1
To begin and define the transcriptional machinery underlying
the genesis of pancreatic gastrin+ cells, we co-stained embryonic
pancreata for gastrin and key transcription factors. Most gastrin+
cells expressed Nkx6.1, Nkx2.2 and stained weakly for Pdx1
(Fig. 3). Gastrin cells never expressed high levels of Pdx1, which is
a hallmark of beta-cells.
Gastrin expressing cells originate from Ngn3+ progenitor
cells
Genetic lineage tracing studies have shown that Ngn3+ cells give
rise to all endocrine cells in the pancreas [1], as well as most
enteroendocrine cells in the intestine, including G cells [5]. To
determine if gastrin+ cells derived from Ngn3-expressing progen-
itors, we used transgenic mice that express Cre recombinase
driven by a BAC containing the Ngn3 promoter, combined with
an indelible Cre reporter transgene (ngn3-Cre; Rosa26-LSL-YFP).
Co-staining of e15.5 pancreata for YFP and gastrin revealed that
all gastrin+ cells are YFP+ (Fig. 4). This result indicates that all
gastrin+ cells in the embryonic pancreas are progeny of cells that
previously expressed Ngn3. Additionally, examination of ngn32/2
pancreata at e15.5 showed no staining for gastrin, in contrast to an
abundant signal in wild type littermates (Fig. 5A). Similar results
were obtained in RT-PCR densitometry analysis of RNA
extracted from wild type (41,893 arbitrary units) and ngn32/2
(1,592 arbitrary units) pancreata at e14.5 (Fig. 5A). Significant
reduction in gastrin RNA levels was also observed in microarray
analysis of ngn32/2 pancreata at e12.5 (Fig. 5C). Thus, gastrin+
cells represent a 6th fate of Ngn3+ pancreatic endocrine progenitor
cells.
Down-stream transcription factors required for
pancreatic gastrin expression
To dissect out the additional genetic requirements for gastrin+
cell formation in the developing pancreas, we examined embry-
onic pancreata from mice deficient for key transcription factors
known to affect the formation of specific endocrine cell types.
nkx2.2-deficient embryos did not show gastrin staining (Fig. 5B),
and microarray analysis of nkx2.22/2 pancreata revealed a 70%
decrease in the level of gastrin mRNA compared with wild type.
We also observed a decrease in the expression of gastrin mRNA in
the pancreas of neuroD1 mutants, as well as in mice doubly
deficient for nkx2.2 and neuroD1 (Fig. 5B).
Mice deficient for arx showed 70% reduction in the levels of
gastrin mRNA (Fig. 5C), in contrast to pax42/2 embryos, which
had a slight elevation in gastrin levels compared to wild type
(Fig. 5C). However pax42/2 embryos did not reveal any elevation
in gastrin by immunostaining (data not shown). Finally, we
examined pax62/2 embryos. These mutants had no glucagon+
gastrin+ cells (presumably reflecting the requirement for Pax6 in
the formation of alpha cells), but glucagon2 gastrin+ cells could be
observed in normal numbers, indicating that Pax6 is not necessary
for the formation of G cells in the pancreas (Fig. 5D).
These results indicate that gastrin expression in the embryonic
pancreas is totally dependent on Ngn3, and to a lesser extent
dependent on Nkx2.2, NeuroD1 and Arx, but not on Pax4 or
Pax6.
Gastrin in Embryonic Pancreas
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Gastrin is induced in human ES cells directed to
differentiate to pancreatic endocrine cells
Considerable effort is being invested in the development of
protocols for directed differentiation of embryonic stem cells to
insulin-producing beta cells that could be transplanted to cure
diabetes. Most of these protocols rely on step-wise differentiation
aimed to recapitulate embryonic development of beta cells, from
definitive endoderm to pancreatic and endocrine progenitor cells,
and finally into hormone-expressing cells. We reasoned that such
protocols, which give rise to cultures containing a mix of
pancreatic hormone expressing cells, could be generating
gastrin-expressing cells as well. To test this idea we performed
quantitative RT-PCR analysis on human embryonic stem cells
differentiated into pancreatic endocrine cells using a modified
method that was similar to published protocols [20,21]. As shown
in Fig. 6, gastrin expression was absent when cells were
differentiated into definitive endoderm and pancreatic endoderm
(day 8). However, there was a rapid induction of gastrin expression
as cells were differentiated into endocrine cells. The kinetics of
Figure 1. Gastrin is abundantly expressed in the embryonic pancreas, and disappears after birth. A. Expression of gastrin in e12.5 mouse
pancreas explanted for 3 days. The image was generated by merging 4 confocal slices (Z-stack). Scale bar = 100 mm. B. In vivo expression of gastrin
throughout the pancreas of an e14.5 mouse embryo. The image was generated by merging 11 confocal slices (Z-stack). C. Quantification of gastrin
and insulin expression in E14.5 mouse embryo, using flow cytometry after intracellular staining for hormones. X-axis shows relative intensity of
flurophore labeling insulin, whereas the y axis shows relative intensity of flurophore labeling gastrin. 0.6% of the cells label gastrin, but not insulin
(quadrant Q1), and 0.7% of the cells are labeled with insulin, but not gastrin (quadrant Q4). The 0.04% of cells showing double labeling likely reflects
background. D. Expression of gastrin in the mouse pancreas at different developmental ages. All images were taken on a Nikon C1 confocal
microscope at a 206 or 606magnification. Scale bar, 100 mm.
doi:10.1371/journal.pone.0070397.g001
Gastrin in Embryonic Pancreas
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gastrin expression closely mirrored expression of insulin. Staining
for gastrin in these cells reveal gastrin positive cells (Fig. 6C) which
all co-expressed other hormones, consistent with the notion that
endocrine cells generated in vitro are immature and polyhormo-
nal. This finding suggests that, as in rodent, human ESC-derived
pancreatic endocrine progenitor cells are competent to differen-
tiate into gastrin+ cells. Since beta-cells are the sought-after
product of these protocols it is desirable, and perhaps necessary, to
reduce the expression of by-products such as gastrin in order to
improve efficiency.
Discussion
Pancreatic G cells as a distinct cell type
G cells are well characterized in the adult stomach, where their
product, gastrin, serves a clear physiological function - reducing
the pH in the lumen of the stomach and increasing stomach
motility to accelerate the first steps in digestion of food. Gastric G
cells were shown to co-express a number of key transcription
factors including Pdx1, Nkx6.1, Nkx6.3 and Arx and to derive
from Ngn3+ enteroendocrine progenitors. Genetic studies have
identified a requirement for Pdx1, Ngn3, Nkx2.2, Pax6 and Arx in
the formation of gastric G cells [5,12,13,22–24]. It was previously
observed that during embryonic development, gastrin mRNA is
not expressed in the stomach but rather it is mostly expressed in
the developing pancreas, in both rodents and humans [16,17].
However the significance of this expression pattern received little
attention. Here we have performed a detailed analysis of gastrin
expression in the embryonic pancreas. Consistent with previous
reports, we found that gastrin is abundantly expressed in the
embryonic pancreas and disappears soon after birth. Gastrin is co-
expressed in some embryonic alpha, epsilon and PP cells, but was
Figure 2. Presence of gastrin-expressing cells that do not stain for other islet hormones. Images in panels A–H are from E15.5 mouse
embryos. Arrows indicate cells co-expressing gastrin and other hormones, whereas arrowheads represent cells that express only gastrin. A–E. Co-
staining for gastrin and insulin (A) or somatostatin (B) reveals no overlap. Co-staining for gastrin and glucagon (C), ghrelin (D) and pancreatic
polypeptide (E) reveals some overlap, but some gastrin positive cells are negative for the other hormones. F. Triple staining for glucagon (green),
gastrin (red) and ghrelin (blue) reveals some cells that stain only for gastrin. G–H. Co-staining for gastrin (red) and a cocktail of antibodies against
insulin, glucagon, somatostatin, pancreatic polypeptide and ghrelin (G, H, green) reveals some cells that stain only for gastrin. I. Staining for gastrin
(DAKO) reveals some gastrin+ cells that are negative for insulin and glucagon in e22 Psammomys obesus. J. Co-staining for gastrin (red) and a cocktail
of antibodies against insulin, glucagon, somatostatin, pancreatic polypeptide and ghrelin (green) in e22 Psammomys obesus, reveals cells that stain
only for gastrin. K. Quantification of cells expressing gastrin with glucagon, ghrelin, pancreatic polypeptide or all pancreatic hormenos as percentage
of all cells expressing gastrin at E15.5 (at least 100 cells were counted from different pancreata (n.5)). Scale bar, 100 mm. Values are presented as
mean 6 SE.
doi:10.1371/journal.pone.0070397.g002
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never observed in beta or delta cells. Some gastrin+ cells appear to
express this hormone alone, suggesting that they represent a
distinct cell type, the pancreatic G cell. Observations in the gerbil
Psammomys obesus, using a different gastrin antibody, provide
independent support to this conclusion and suggest that gastrin
expression is an evolutionary conserved aspect of pancreas
development. At the molecular level, we found that pancreatic
G cells derive from Ngn3+ progenitors, and express Nkx2.2,
Nkx6.1 and low levels of Pdx1. We demonstrate using genetic
models that gastrin expression in the fetal pancreas depends on
Ngn3, Nkx2.2 and Arx (and to a lesser extent on NeuroD1) but
not Pax4 or Pax6. Together, these findings identify pancreatic G
cells as a distinct endocrine cell type in the pancreas, adding to the
5 other known endocrine cell types formed in this organ (see
model, Fig. 7).
The genetic program of gastrin expression in the pancreas is
similar to that of alpha cells in that it is dependent on Arx, but also
has unique features best illustrated by the formation of G cells in
the pancreas of Pax62/2 embryos, which lack alpha cells.
Pancreatic G cells also resemble epsilon cells in that both gastrin
and ghrelin are frequently co-expressed with glucagon in the
embryonic pancreas and the expression of both shifts postnataly
from pancreas to stomach. We speculate that these patterns relate
to the evolutionary history of the endocrine system. Glucagon and
Figure 3. Transcription factors expressed in gastrin+ cells. Gastrin+ cells in e15.5 pancreas express Nkx6.1, Nkx2.2 and lower levels of Pdx1.
Yellow arrows mark the cells in the insets. Scale bar, 100 mm.
doi:10.1371/journal.pone.0070397.g003
Figure 4. Pancreatic gastrin cells derive from Ngn3+ endocrine progenitors. Co-staining for gastrin (red) and the progeny of Ngn3+ cells
(anti-GFP, green) in Ngn3-Cre;Rosa26-LSL-YFP e15.5 mice reveals that all gastrin+ cells have passed through a Ngn3-expressing stage. Scale bar,
100 mm.
doi:10.1371/journal.pone.0070397.g004
Gastrin in Embryonic Pancreas
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ghrelin may represent the most ancient hormones responding to
hunger, which later evolved into the multitude of more ‘‘modern’’
hormones with each developing its own, distinct gut/pancreas
location. More work will be required to understand these
dynamics. Our finding that protocols currently used for ES cell
differentiation result in the production of G-cells provides evidence
that these protocols recapitulate embryonic development and
enrich for immature, fetal-type endocrine cells. Further steps will
likely be needed to complete maturation to adult beta cells.
Significance of pancreatic gastrin expression
The function of gastrin in the embryonic pancreas is not known.
Early studies have suggested that gastrin acts as a mitogen to fetal
Figure 5. Transcription factors required for gastrin expression in the embryonic pancreas. A. No expression of gastrin in Ngn32/2
pancreata is shown by immunofluorescence staining and significant gastrin reduction by RT-PCR at e14.5. Densitometry measurement of gastrin RNA
levels (imageJ) shows that gastrin expression in ngn3+/+ pancreata is markedly reduced in ngn3 KO (from 41,893 to 1,592; arbitrary units, the same
area was picked for both bands). B. No expression of gastrin in Nkx2.22/2 pancreata is shown by immunofluorescence staining. Microarray analysis
shows reduced expression of gastrin RNA in Nkx2.22/2, NeuroD12/2 and double knockout embryos at e14.5. Values are presented as mean 6 SE. C.
Reduced expression of gastrin in Ngn32/2 and Arx2/2 but not in Pax42/2 embryos at e12.5 (microarray analysis). Values are presented as mean6 SE.
D. Pax62/2 embryonic pancreata have reduced numbers of gastrin+ glucagon+ cells, but gastrin+ glucagon2 cells are still observed. Scale bar,
100 mm for all panels.
doi:10.1371/journal.pone.0070397.g005
Gastrin in Embryonic Pancreas
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e70397
beta cells [25–27], but later studies found little support for this
hypothesis. The issue was again raised more recently, with reports
that gastrin may induce beta-cell regeneration alone, after 95%
pancreatectomy [27], or if co-administered with EGF in the NOD
mouse model [28,29]. However, gastrin-deficient mice have no
significant pancreatic phenotype [30] and transgenic overexpres-
sion of gastrin in beta cells also resulted in normal pancreatic
development [31]. Thus, while pharmacologic administration may
have an effect in some circumstances, the physiologic transient
pancreatic expression of gastrin may serve no function and, as
noted above, may merely reflect the evolutionary history of the
endocrine system, similar to pancreatic ghrelin expression and
primary transition cells [32].
We show that the expression of gastrin is detected already at
e12.5. An interesting possibility is that gastrin+ cells may originate
from alpha, epsilon or PP cells. We cannot exclude this possibility
but believe it is unlikely. One argument is that it was previously
reported that in pax6 knockout the expression of glucagon is
abolished. We show that on similar pax6 knockout background the
expression of gastrin is not affected.
During adult life, gastrin can be re-expressed in the pancreas in
the form of functional islet cell tumors, ,40% of which are
gastrinomas [33–35]. The cell of origin of pancreatic gastrinomas
remains unknown. They could derive from rare gastrin+ cells that
survived in the pancreas from fetal life; from reprogramming of
adult islet cells that undergo malignant transformation; or from
Figure 6. Gastrin expression in human embryonic stem cells. A–B. Quantitative RT-PCR on RNA extracted from human embryonic stem cells,
directed to differentiate into definitive endoderm, pancreatic progenitor cells, endocrine progenitor cells, and hormone expressing cells. Note that
the kinetics of gastrin induction are similar to those of insulin expression. Values are normalized to beta tubulin and expression differences are
relative to definitive endoderm (DE). C. Staining human embryonic stem cells directed to hormone expressing cells for gastrin, insulin, glucagon and
somatostatin reveals gastrin positive cells (different samples).
doi:10.1371/journal.pone.0070397.g006
Gastrin in Embryonic Pancreas
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aberrant postnatal activation of the embryonic program of
endocrine differentiation. Genetic lineage tracing studies will be
needed to address this problem; such studies may also reveal
whether embryonic G cells are eliminated, or whether they
downregulate gastrin expression and resolve to another cell type.
However, such experiments are beyond the scope of this study.
Finally, pancreatic islet tumors rarely express additional hormones
such as Vasoactive Intestinal Polypeptide (VIP) and parathyroid
hormone-related peptide (PTHRP). It will be interesting to test
whether, like gastrin, these hormone are transiently expressed
during normal pancreas development.
Determinants of islet cell composition
Our data on embryonic gastrin expression, together with the
similar dynamics of ghrelin expression, highlight a striking
difference between the composition and relative abundance of
endocrine cells in the embryonic and adult pancreas. While Ngn3+
cells generate 6 different cell types in the fetal endocrine pancreas,
postnatal processes remodel this starting population to obtain a
different cell composition in the adult islet (Fig. 7). It will be
interesting to study how differential rates of proliferation and
survival affect this process and the molecular mechanisms that
impact postnatal hormone gene expression.
Materials and Methods
Ethics Statement
The joint ethics committee (IACUC) of the Hebrew University
and Hadassah Medical Center approved the study protocol for
animal welfare. The Hebrew University is an AAALAC Interna-
tional accredited institute. Experiments with P. obesus were
performed in accordance to the regulations specified under the
Protection of Animals Act by the authority in Denmark, European
Union and Novo Nordisk A/S.
Mice
We used either ICR mice from Harlan, Israel or knockout
strains as previously described: Homozygous Ngn3-CreER (serving
as Ngn3 nulls) [36], BAC transgenic Ngn3-Cre [37], ROSA26-LSL-
YFP [38], Nkx2.22/2 [32], NeuroD2/2 [39], Pax62/2 [40], Arx2/2
[41], Pax42/2 [42]. Experiments with P. obesus were performed in
accordance to the regulations specified under the Protection of
Animals Act by the authority in Denmark, European Union and
Novo Nordisk A/S.
Pancreatic explants
Pancreatic buds from embryonic day (e) 12.5 mouse embryos
were cultured in DMEM supplemented with 10% fetal bovine
serum, containing 100 U/ml penicillin and 100 mg/ml strepto-
mycin, as described previously [43]. Explants were cultured on
microporous membranes (Whatman, nucleopore Track-Etch,
diameter 13 mm, pore size 8.0 micron) and no medium was
added on top of the filter, so that the tissue grew at the air/
medium interface. Medium was changed every other day.
Immunostaining, antibodies and microscopy
All images are representative of at least 6 different pancreata.
Whole mount pancreas immunostaining was performed essen-
tially as previously described [44]. For all other immunostaining,
pancreata (e12.5-p7) were surgically removed and fixed in 4%
buffered zinc-formalin for 2 hours at 4uC, dehydrated in an
ethanol series, cleared in histoclear and embedded in Paraplast
(Kendall). When required, antigen retrieval was performed using a
citrate buffer and a pressure cooker. Primary antibodies used in
this study included: Rabbit anti-gastrin (1:200, Cell Marquee),
rabbit anti-gastrin (1:200, Dako), guinea pig anti-gastrin (1:50,
Progen), mouse anti-gastrin (1:50, Abnova), guinea pig anti-insulin
(1:200, Abcam), goat anti-pancreatic polypeptide (1:50, Abcam),
mouse anti-glucagon (1:800, Beta Cell Biology Consortium),
mouse anti-somatostatin (1:400, Beta Cell Biology Consortium),
goat anti-ghrelin (1:100, Santa Cruz), goat anti-GFP (1:500,
Abcam), goat anti-Pdx1 (1:2,500, a generous gift of Chris Wright),
mouse anti-Nkx2.2 (1:50, Developmental Studies Hybridoma
Bank) and mouse anti Nkx6.1 (1:400, Beta Cell Biology
Consortium). For DNA counterstain we used Sytox (1:500,
Invitrogen). Rabbit anti-Gastrin from Cell Marque was used in
the images shown unless stated otherwise. Guinea-pig and mouse
anti gastrin were used to confirm the rabbit antibody findings. The
gastrin antibodies produced by Progen, Cell-Marque and DAKO
cross-react with CCK (100, 50, 20% cross-reactivity respectively)
whereas the Abnova antibody does not. Secondary antibodies
were from Jackson immune-research, used at 1:200. Immunoflu-
orescence images were captured on a Nikon C1 confocal
microscope or Olympus FV1000.
Flow cytometry
For FACS analysis, e14.5 pancreata or livers from wild type
embryos were dissociated to single cells with trypsin and stained
with guinea pig anti-insulin (1:800, Abcam) followed by Alexa488
anti-guinea pig (1:500, Jackson Immunoresearch), and with Rabbit
anti-gastrin (1:500, Cell Marquee) followed by Cy5 anti-rabbit
(1:800, Jackson Immunoresearch).
RT-PCR
Total RNA (n= 5) was prepared using Qiagen RNeasy microkit
according to the manufacturer’s protocol. Total RNA (100 ng) was
used for first-strand cDNA synthesis using random primers
(Roche) and reverse transcriptase (ImProm-II,Promega). We
Figure 7. Model placing gastrin cells in the transcriptional
hierarchy of endocrine cells in the pancreas.
doi:10.1371/journal.pone.0070397.g007
Gastrin in Embryonic Pancreas
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checked the existence or absence of Gastrin mRNA in wild type
embryos, wild type adult pancreas and Ngn3-deficient pancreata.
PCR was performed using GoTaq Green Master Mix (Promega).
Primers were designed to bridge introns to avoid amplifying
genomic DNA contamination if present: mGastrin: F-59-
cccagctctgtggacaagatgcctc-39 and R-59- gcatcctgtagctgggagcgg -
39; hB-tubulin F-59- gatacctcaccgtggctgct -39 and R-59- agag-
gaaaggggcagttgagt – 39; hInsulin F-59- gaaccaacacctgtgcggctca - 39
and R-59- tgcctgcgggctgcgtctagt - 39; hGastrin F-59- cagagccagtg-
caaagatca - 39 and R-59- agagacctgagaggcaccag - 39. Note that the
gastrin primers do not cross-react with the CCK gene.
Micro-Array analysis
Nkx2.2 and NeuroD Pancreas tissue was collected from
either Nkx2.22/2, NeuroD2/2, Nkx2.22/2 NeuroD2/2 or WT
staged embryos at e14.5 (n = 4). Total pancreata were collected,
stored individually in RNase Later (Ambion), and genotyped. Four
groups of wild-type and mutant tissues were individually pooled.
Samples of total RNA were processed for microarray analysis by
using the Mu19k A gene chip according to manufacturer’s
instructions (Affymetrix). Chip performance, background levels,
and presence/absence calls were assessed by using MICROAR-
RAY SUITE software (Affymetrix). The processing of data was
performed in GenePattern (Broad Institute).
Ngn3, Arx and Pax4. Pancreas tissue was collected from
Ngn32/2, Arx2/2, Pax42/2 or WT staged embryos at e12.5
(n = 3). Total pancreata were collected and samples of total RNA
were processed for microarray analysis using Affymetrix protocol
for affymetrix 430 arrays. The processing of data was performed in
Genesifter.
Pancreas differentiation from human pluripotent stem
cells
Human pluripotent stem cells were differentiated into pancre-
atic tissue using methods adapted from previous reports [20,21].
The human embryonic stem cell line WA09 (WiCell) was
maintained in feeder-free culture conditions on Matrigel (BD
Biosciences) in mTesR1 medium (Stem Cell Technologies). For
differentiation, cells were treated with Dispase (Invitrogen) and
plated into a 24-well plate. For definitive endoderm induction, 80–
90% confluent cells were treated with Activin A (100 ng/ml; R&D
Systems) for three days in RPMI 1640 medium (Invitrogen)
containing 0%, 0.2%, and 2.0% dFBS (Thermo Scientific) on days
1, 2, and 3. The definitive endoderm was further cultured for two
days in the presence of FGF10 (50 ng/ml; R&D Systems) and
noggin (50 ng/ml; R&D Systems) in RPMI 1640+2.0% dFBS. For
induction of pancreatic endoderm, cells were then treated for four
days with all-trans retinoic acid (2 mM; Stemgent), KAAD
(0.25 mM; Stemgent), FGF10 (50 ng/ml), and noggin (50 ng/ml)
in DMEM medium (Invitrogen) with B27 supplement (2%;
Invitrogen). This was followed by five days of culture in EGF
(50 ng/ml; R&D Systems) in DMEM/B27, and then six days in
Exendin-4 (50 ng/ml; Tocris Bioscience) and DAPT (10 mM;
Stemgent) in DMEM/B27.
Statistics
Values are presented as mean 6 SE. P values were determined
using the 2-tailed Student’s t test with unequal variance. P values
of less than 0.05 were considered significant. ***, p,0.001, **,
p,0.01, * p,0.05.
Supporting Information
Figure S1 Controls for FACS analysis quantifying
gastrin+ cells in the embryonic pancreas. Left panels:
e14.5 pancreata from wild type mice were dissociated to single
cells, stained with fluorescent antibodies against either insulin or
gastrin and analyzed by FACS. The panels show that in these
preps, 0.7% of pancreatic cells are insulin+ and 0.6% are gastrin+
cells. Right panels: e14.5 livers from wild type mice were
dissociated to single cells, stained with fluorescent antibodies
against insulin and gastrin and analyzed by FACS. The panels
show that liver cells are negative both for insulin and gastrin
antibodies suggesting for specificity of our antibodies.
(TIF)
Figure S2 More evidence for endocrine cells in the
embryonic pancreas that express only gastrin. Sections of
e14.5 pancreata co-stained for gastrin (red) and a cocktail of
antibodies against insulin, glucagon, somatostatin, pancreatic
polypeptide and ghrelin (green). Some cells that stain only for
gastrin, while some co-express gastrin and other hormones
(appearing in yellow).
(TIF)
Figure S3 Gastrin expressing cells do not stain for CCK.
Sections of several e15.5 pancreata stained with an antibody
specific for gastrin that does not cross react with CCK (Abnova).
(TIF)
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